Ignite Creation Date:
2025-12-25 @ 3:19 AM
Ignite Modification Date:
2025-12-26 @ 1:58 AM
Study NCT ID:
NCT00270205
Status:
COMPLETED
Last Update Posted:
2021-11-04
First Post:
2005-12-21
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-01
Start Date Type:
None
Primary Completion Date:
2010-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-09
Completion Date Type:
ACTUAL
First Submit Date:
2005-12-21
First Submit QC Date:
None
Study First Post Date:
2005-12-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-09-07
Results First Submit QC Date:
None
Results First Post Date:
2011-10-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-02-02
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2021-11-02
Last Update Post Date:
2021-11-04
Last Update Post Date Type:
ACTUAL